Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Anxiety drug Clonazepam recalled for mislabeling
Anxiety drug Clonazepam recalled for mislabeling; could cause a 'life-threatening' event
Clonazepam, an anxiety drug, is being voluntarily recalled for the potential to cause a “life-threatening” event.
Popular Anti-Anxiety Drug Recalled Due to ‘Possibly Life-Threatening' Error
What Happened? Pharmaceutical company Endo Inc. issued the recall after discovering that cartons of the anti-anxiety drug were mislabeled with incorrect dosage strengths and National Drug Codes (NDCs).
Some Clonazepam Pills Recalled Over Incorrect Doses on Label, F.D.A. Says
The agency warned that adults and children who inadvertently took a higher dose of clonazepam than prescribed could experience side effects, including “significant” sedation, confusion, dizziness, diminished reflexes, the loss of muscle control and muscle weakness.
4d
Clonazepam recall expanded after misprinting on packaging
The company is worried mislabeling could lead to unintentionally taking higher doses and adverse side effects.
4d
on MSN
Anxiety drug clonazepam recalled due to potentially 'life-threatening' labeling error
Clonazepam, an anxiety drug, has been recalled because of a labeling error that could result in harmful consequences.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Cabinet OKs ceasefire deal
US Navy plane shadowed
To attend inauguration
Thanksgiving storm forecast
Senate report slams airlines
Request to bar player denied
World's oldest man dies
Accuses judge in assets case
Defamation suit to proceed
25 years for killing neighbor
LA homeless sweeps halted
Man sentenced for threats
Mutual HIV transplants rule
Visiting border with Abbott
Wins approval for $6.6B loan
Rolling back DEI policies
Alleged impropriety probe
US new home sales tumble
Rays stadium deal deadline
Expanded coverage proposal
MO trans care ban upheld
International Emmys winners
Local dengue case in Texas
Excluded from EV tax plan
North Carolina fires coach
Safety issue grounds Osprey
Consumer confidence rises
MA synagogues threat plea
Settles suit over pay equity
Feedback